PR001079 (Project)

Id Namespace:

UCSD Metabolomics Workbench

Identifier Namespace (Entity type)

Dcc Asset:

MW submission packet 20250922.zip

Processed File (Entity type)

Dcc:

Metabolomics

DCC (Entity type)

Persistent Id:http://dx.doi.org/10.21228/M8797T

Description:We investigated the effects of a RAR beta 2 agonist, AC261066, on the hepatic metabolites changed in high fat fed NAFLD mouse model. We suggest that AC261066 has potential therapeutic relevance for the prevention/treatment of NAFLD and NASH.

Results found

Linked to

	Label	Description
	PPR00001 Project (Entity type)	Metabolomics
	SU001757 Subject (Entity type)	A subject from Metabolomics produced as part of the PR001079 project
	SA154622 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project
	SA154590 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project
	SA154574 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project
	SA154616 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project
	SA154593 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project
	SA154619 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project
	SA154662 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project
	SA154579 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001079 project

PPR00001

Project (Entity type)

Metabolomics

SU001757

Subject (Entity type)

A subject from Metabolomics produced as part of the PR001079 project

SA154622

Biosample (Entity type)